We're telling the stories of the people and places that will be profoundly affected by the "Ending the HIV Epidemic" plan as it unfolds, and seeking to answer the question: Can this plan truly end HIV transmission in the U.S.?
Harold Phillips’ deep resume may well bring muscle to a position that’s often seen as window dressing—and that was left conspicuously empty while Trump was president.
Like the treatment divide of the early HIV/AIDS crisis, the uneven distribution of COVID-19 vaccines poses a global threat.
In ‘To End a Plague,’ Emily Bass chronicles the history of PEPFAR and the activists who moved then-President George W. Bush to take action.
With its powerful former head Deborah Birx, M.D., now retired after her Trump-era COVID fumble, the program awaits a new top dog—and perhaps a new life.
Defining moments and lessons learned from leading the world’s first HIV and AIDS nonprofit.
Working at Whitman-Walker Clinic in the early 1980s, George Bellinger Jr. was among the first to see posters warning people to be careful and to wear condoms.
It’s been 40 years since researchers and journalists first wrote about a strange new syndrome—but even prior, it was clear something was brewing.
One of the most effective ways to make sure LGBTQ+ rights are on the agenda is to get a seat at the table.
Despite the interruptions in testing and treatment caused by the COVID-19 pandemic elsewhere, Julio Montaner, M.D., and colleagues in British Columbia have nearly eliminated HIV there.
PACHA started with a bang in the Reagan era. Since then, and especially under Trump, it’s never had much real impact. Could that change?